fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Remembering Dr Jackie Stone – 1965-2024

Written by | 7 Oct 2024

We were deeply saddened to read of the untimely death of Dr Jackie Stone on 3rd October 2024. There have been many moving tributes to her on social… read more.

Most pregnant people got vaccinated for COVID-19 in 2022

Written by | 5 Oct 2024

A study of more than 28,000 pregnancies from 2022 has found that the majority of pregnant people received the COVID-19 vaccine during its initial release. The study, co-led… read more.

Big gaps seen in home medical test use by older adults

Written by | 3 Oct 2024

With a fresh wave of free COVID-19 rapid tests now shipping to households nationwide, and many other types of at-home medical tests now available on store shelves and… read more.

Pain identified as dominant symptom in long Covid

Written by | 31 Aug 2024

Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL (University College London) researchers. The study,… read more.

FDA approval & authorization for Omicron KP.2-adapted COVID-19 Vaccine – BioNTech SE + Pfizer

Written by | 30 Aug 2024

Pfizer Inc. and BioNTech SE announced that the FDA has approved the supplemental Biologics License Application for individuals 12 years of age and older (COMIRNATY (COVID-19 Vaccine, mRNA),… read more.

Excessive patient loads were the greatest cause of moral distress among health personnel during the pandemic

Written by | 27 May 2024

Moral distress is the psychological harm that arises when people are forced to witness or perform actions that clash with their moral values. It is a problem that… read more.

How long COVID survivors are revolutionizing health care

Written by | 29 Mar 2024

To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just… read more.

Positive topline results from phase II study evaluating Ampligen (rinatatolimod) for the treatment of post-COVID conditions – AIM ImmunoTech Inc

Written by | 18 Feb 2024

AIM ImmunoTech Inc. announced positive topline results from the Company’s Phase II study evaluating the efficacy and safety of Ampligen as a potential therapeutic for people with the… read more.

Ten per cent treatment boost needed to shift NHS Covid backlog

Written by | 21 Jan 2024

The NHS must treat at least 10 per cent more non-emergency hospital cases a month if it is to successfully start reducing the hefty backlog caused by the… read more.

France recorded ‘post-COVID’ surge in meningococcal disease

Written by | 13 Jan 2024

An unprecedented resurgence in invasive meningococcal disease followed the lifting of pandemic restrictions in France, according to a paper published in the Journal of Infection and Public Health… read more.

‘Long flu’ has emerged as a consequence similar to long COVID

Written by | 21 Dec 2023

Since the COVID-19 pandemic began, extensive research has emerged detailing the virus’s ability to attack multiple organ systems, potentially resulting in a set of enduring and often disabling… read more.

Final results for VV116 (mindeudesivir hydrobromide) shows efficacy in COVID 19 trial – Junishi Biosciences

Written by | 2 Dec 2023

Junshi Biosciences has revealed the final results for its Covid-19 pill VV 116 (mindeudesivir hydrobromide), indicating its efficacy. The data, which was published in The Lancet Infectious Diseases… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.